This document is an excerpt from the EUR-Lex website
Document 32026R1073R(01)
Corrigendum to Commission Delegated Regulation (EU) 2026/1073 of 6 March 2026 amending and correcting Delegated Regulation (EU) 2023/361 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (OJ L, 2026/1073, 13.5.2026)
Corrigendum to Commission Delegated Regulation (EU) 2026/1073 of 6 March 2026 amending and correcting Delegated Regulation (EU) 2023/361 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (OJ L, 2026/1073, 13.5.2026)
Corrigendum to Commission Delegated Regulation (EU) 2026/1073 of 6 March 2026 amending and correcting Delegated Regulation (EU) 2023/361 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (OJ L, 2026/1073, 13.5.2026)
C/2026/4320
OJ L, 2026/90491, 19.6.2026, ELI: http://data.europa.eu/eli/reg_del/2026/1073/corrigendum/2026-06-19/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
ELI: http://data.europa.eu/eli/reg_del/2026/1073/corrigendum/2026-06-19/oj
|
Official Journal |
EN L series |
|
2026/90491 |
19.6.2026 |
Corrigendum to Commission Delegated Regulation (EU) 2026/1073 of 6 March 2026 amending and correcting Delegated Regulation (EU) 2023/361 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases
( Official Journal of the European Union L, 2026/1073, 13 May 2026 )
On page 14, Annex, Part 2, point 2, in the amendments of Part 3, point 3.3.(a) of Annex IX to Delegated Regulation (EU) 2023/361:
for:
|
‘(a) |
have been vaccinated against LSD at least 28 days prior to the date of dispatch and remain on that date within the immunity period in accordance with the instructions of the vaccine manufacturer, or’, |
read:
|
‘(a) |
have been vaccinated against LSD at least 28 days prior to the date of collection and remain on that date within the immunity period in accordance with the instructions of the vaccine manufacturer, or’. |
ELI: http://data.europa.eu/eli/reg_del/2026/1073/corrigendum/2026-06-19/oj
ISSN 1977-0677 (electronic edition)